Study of the Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49
Condition: InfluenzaIntervention: Biological: VAX161-01C vaccineSponsor: VaxInnate CorporationCompleted - verified May 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 30, 2012 Category: Research Source Type: clinical trials
Study of the Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49
Condition: InfluenzaIntervention: Biological: VAX161-01C vaccineSponsors: VaxInnate Corporation; VaxInnate CorporationActive, not recruiting - verified May 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 30, 2012 Category: Research Source Type: clinical trials
Study of the Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49
Condition: InfluenzaIntervention: Biological: VAX161-01C vaccineSponsor: VaxInnate CorporationCompleted - verified May 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 30, 2012 Category: Research Source Type: clinical trials